Roche has launched its uPath enterprise software for digital pathology, billing it as an improvement in speed and performance compared to its previous version known as Ventana Virtuoso. According to ...

- Innovative design integrates powerful imaging and analysis tools for more efficient workflow - Personalized workflow software allows pathologists to move seamlessly between a variety of stains in a ...

Roche announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung cancer (NSCLC). The algorithm provides pathologists with ...

Roche announced the CE-IVD launch of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine the best ...

Basel, June 26, 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung ...

In combination with the VENTANA DP 200 slide scanner and Roche uPath enterprise software, the new algorithms provide innovative digital pathology solutions to advance personalised healthcare Nearly ...

TUCSON, Ariz., Jan. 15, 2019 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its innovative uPath enterprise software[1] for digital pathology. Offering a new standard ...

uPath PD-L1 (SP263) image analysis uses automated pre-computing and one-click scoring to enable quicker and accurate detection and measurement of tumour cell staining positivity Roche advances ...

Faster, more accurate diagnoses are critical with non-small cell lung cancer, which accounts for about 85 percent of all lung cancer cases Basel, June 26, 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) ...